Company profile: Cellesce
1.1 - Company Overview
Company description
- Provider of patient-derived organoid (PDO) technology and 3D organoids for drug discovery assays, offering fee-for-service custom development and scaled manufacturing of PDO lines, plus comprehensive enablement services including sourcing, line development, technology access, and quality management systems. Biochemical engineering expertise in cell expansion; based in Cardiff, UK.
Products and services
- Enablement of PDO Technology: Quality-managed service that delivers comprehensive PDO technology support, covering sourcing, line development, technology access, and quality management systems for 3D organoid applications
- Fee-for-Service Development and Manufacturing: Custom-engineered program that architects and constructs patient-derived organoid (PDO) lines, enabling custom development and scaled fabrication for 3D drug discovery assays
- Organoid Cell Expansion: Scalable service that amplifies 3D organoids for drug discovery assays, leveraging biochemical engineering expertise to expand patient-derived organoid (PDO) lines
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cellesce
CrestOptics
HQ: Italy
Website
- Description: Provider of advanced fluorescence microscopy systems and modules, including CICERO widefield and spinning disk confocal for inverted/upright setups with wide spectral range and high resolution; X-Light V3 spinning disk confocal enabling dual-camera, high-speed, large FOV imaging; DeepSIM super-resolution module; and VisiView software for integrating and optimizing imaging protocols.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CrestOptics company profile →
Cell Microsystems
HQ: United States
Website
- Description: Provider of single-cell biology products, including the CellRaft AIR System for single-cell/colony culture; BioFlux Systems to emulate in vivo shear flow for drug discovery and cell analysis; CERO 3D Incubator & Bioreactor for organoid, spheroid, and tissue research; CASY Cell Counter & Analyzer for cell counting and viability without dyes or reagents; TIGR Tissue Grinder & Dissociator; and IonFlux Mercury Systems for ion channel research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cell Microsystems company profile →
Sarissa Biomedical
HQ: United Kingdom
Website
- Description: Provider of minimally invasive microelectrode electrochemical biosensors that detect purines and other neurochemicals, such as serotonin and dopamine, in blood to aid diagnosis and monitoring of neurological disorders. Solutions offer exquisite sensitivity, broad linear range, rapid measurements, and high accuracy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sarissa Biomedical company profile →
Ethypharm
HQ: France
Website
- Description: Provider of pharmaceutical products for the treatment of pains and addictions, designing, formulating, developing, manufacturing, and marketing them.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ethypharm company profile →
GenVault
HQ: United States
Website
- Description: Provider of sample management solutions for disease diagnosis, research, identification and criminal investigations, offering secure, GxP-compliant biorepository storage for over 60,000,000 samples (ambient to cryogenic), specialized transport and lab relocation with full chain-of-custody and GxP/USDOT compliance, and end-to-end bioinventory support—accession, monitoring, tracking, reporting and disposal—via a secure online portal.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenVault company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cellesce
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cellesce
2.2 - Growth funds investing in similar companies to Cellesce
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cellesce
4.2 - Public trading comparable groups for Cellesce
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →